-
J Ethnopharmacol: Protective effect of Dan Lamp Brain Capsules on Brain Microvascular Endothelial Cells
Time of Update: 2022-10-02
Previous studies have shown that DDTNC prevents cerebral ischemia-reperfusion injury in MCAO rats, and DDTNC-CSF improves the viability of OGD/R-damaged cerebral microvascular endothelial cells (BMECs).
Previous studies have shown that DDTNC prevents cerebral ischemia-reperfusion injury in MCAO rats, and DDTNC-CSF improves the viability of OGD/R-damaged cerebral microvascular endothelial cells (BMECs).
-
Interaction of human eye Tenon's capsule fibroblasts and human corneal epithelial cells in a co-culture system
Time of Update: 2022-08-30
Given that corneal epithelium and subconjunctival tissue (including Tenon's capsule fibroblasts) interact through tears, HCE cells were examined in a co-culture system for BAC-induced transdifferentiation.
Given that corneal epithelium and subconjunctival tissue (including Tenon's capsule fibroblasts) interact through tears, HCE cells were examined in a co-culture system for BAC-induced transdifferentiation.
-
Microchip's "Cioroni Capsule" launches Phase III clinical trial for small cell lung cancer
Time of Update: 2021-05-02
Recently, the Insight database revealed that Microchip Bio-Sioroni Capsules has launched a Phase III clinical trial for the treatment of small cell lung cancer that has progressed or recurred after a 2-line system of chemotherapy.
-
Microchip's "Cioroni Capsule" launches Phase III clinical trial for small cell lung cancer
Time of Update: 2021-04-18
Recently, the Insight database revealed that Microchip Bio-Sioroni Capsules has launched a Phase III clinical trial for the treatment of small cell lung cancer that has progressed or recurred after a 2-line system of chemotherapy.
-
Zhengda Tianqing capsule of androtinib hydrochloride was approved as the third indication - the third line treatment of small cell lung cancer.
Time of Update: 2019-09-06
On September 4, China biopharmaceutical announced that its subsidiary company, Zhengda Tianqing Pharmaceutical Group Co., Ltd., independently developed the anti-tumor drug "androtinib hydrochloride ca